Abstract
Objective:Treatments for psoriatic arthritis (PsA) range from high-cost agents such as tumour necrosis factor (TNF) inhibitors evaluated in large randomised control trials (RCTs) and low-cost disease-modifying anti-rheumatic drugs (DMARDs) studied...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have